FDA Investigator Tamara Brey

Tamara Brey has conducted inspections on 51 sites in 5 countries as of 26 Sep 2001. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
51
Last Inspection Date:
26 Sep 2001
Investigator Role:
FDA Investigation Participant
Redica ID:
100008662
Countries of Inspections:
United States of America, Canada, Italy, United Kingdom of Great Britain and Northern Ireland, Germany
FDA Investigators that have inspected at least one site in common with Tamara Brey:
Adam J Taylor, Alicia M Mozzachio, Amanda Dinaro, Amanda S Zorn, Ana L Kewes, Anastasia M Shields, Andrew A Leboeuf, Anna Flynn, Anthony F Lorenzo, Audrey Dela Cruz, Bijoy Panicker, Bradley J Maunder, Brentley S Collins, Brian D Nicholson, Bruce H Mccullough, Burnell M Henry, Carrie Ann Plucinski, CDR Sean T Creighton, Chad E Schmear, Chad J Whitwell, Cheryl A Kmiec, Chiang Syin, PhD, Christina A Miller, Christopher B Harding, Christopher D Leach, Clotia Cabbey Mensah, Creighton T Tuzon, Daniel C Kearns, Daniel Kearns, Darrell E Luedtke, David J Gasparovich, David Perkins, Dawnna D Brown, Debra I Love, Debra Lboyd Seale, Denise L Burosh, Dolores Harper, Dr. Gang Wang, PhD, Dr. Guang Gao, PhD, Elliot P Cowam, PhD, Eric M Mueller, PharmD, Eric S Pittman, Gene D Arcy, Gregory R Dill, Helen B Ricalde, Humera T Khan, Jacqueline Mdiaz Albertini, James T Karpus, James W Plucinski, Jan B Welch, Jason F Chancey, Jeanne J Chiu, Jeanne M Morris, Jesse A Vazquez, Joan A Loreng, John D White, John M Seale, Joseph A Morkunas, Joshua M Adams, Julie D Bringger, Karen Emasley Joseph, Kathleen B Swat, Kimberly Lewandowski Walker, Kristen E Szenderski, Kujtim Sadiku, Kyran R Gibson, Laiza V Garcia, Lakisha M Williams, Lana K Waselewski, Larry F Hallberg, Laurie A Haxel, Lee Terry Moore, Lequita M Mayhew, Lisa Hayka, Lisa Hornback, Lorelei S Jarrell, Maksim A Levenchuk, Margaret Torres Vazquez, Mark E Frank, Martha T Olone, Matthew J Sienko, Maureen C Melvin, Michael D Robinson, Michele L Glendenning, Nancy J Lucas, Nicholas F Lyons, Nicholas P Diorio, Nicholas Z Lu, Nicole J Clausen, Nicole K Trudel, Nicole S Williams, Norman K Starks, Norman L Brown, Norman Wong, Omotunde O Osunsanmi, Pablo Alcantara, Paola S Barnett, Patricia A Mcilroy, Patrick E Gainer, Pauline N Logan, Phung Thien Nguyen, Prabhu P Raju, Rachel T Evans, Rafael Padilla, Robert L Stevenson, Roberta W Cunningham, Rose Ashley, Russell K Riley, Samuel T Walker, Samuel W Labinjo, Sarah B Tanksley, Sarah Forney, Shafiq S Ahadi, Simone E Pitts, Stephen D Eich, Sullan, Susan A Zullo, PhD, Susan M Jackson, Susan P Bruederle, Tara C Alcazar, That Q Dang, Todd M Stankewicz, Todd Q Dang, Travis S Bradley, Vioela J Caze, William R Weissinger, Yuanyuan Li, Yvonne E Lozano

Tamara Brey's Documents

Publish Date Document Type Title
March, 2001 FDA 483 E. Merck KGaA - Form 483, 2001-03-22
January, 2000 EIR Angiotech (Manan Medical Products, Inc.) - EIR, 2000-01-26
December, 2000 EIR Baxter Healthcare Corporation - EIR, 2000-12-05
November, 2000 EIR Ferraris Medical, Ltd. - EIR, 2000-11-02
March, 2001 FDA 483 Response E. Merck KGaA - Form 483R, 2001-04-03
January, 2000 FDA 483 Response Angiotech (Manan Medical Products, Inc.) - Form 483R, 2000-01-26
November, 2000 FDA 483 Ferraris Medical LTD - Form 483, 2000-11-02
March, 2000 EIR Sterigenics U.S., LLC - EIR, 2000-03-27
October, 2000 FDA 483 Divex Ltd. - Form 483, 2000-10-26
March, 2001 EIR E. Merck KGaA - EIR, 2001-06-07
January, 2000 FDA 483 Angiotech (Manan Medical Products, Inc.) - Form 483, 2000-01-26
April, 2001 FDA 483 Lang Dental Mfg Co, Inc. - Form 483, 2001-04-13
April, 2000 FDA 483 Canix Sterilizer - Form 483, 2000-04-28
August, 2000 EIR Efoora, Inc. dba Virotek, L.L.C. - EIR, 2000-08-03
December, 2000 EIR Baxter Healthcare Corporation - EIR, 2000-12-21
July, 2001 FDA 483 Unilever Home & Personal Care - USA - Form 483, 2001-07-19
March, 2001 EIR DentSply Sirona - EIR, 2001-03-15
October, 2000 EIR Abbott Laboratories - EIR, 2000-10-13
April, 2000 EIR Canix Sterilizer Inc. - EIR, 2000-04-28
August, 2000 EIR Zuzga, John, M.D. - EIR, 2000-08-01
February, 2000 FDA 483 Medgyn Products, Inc. - Form 483, 2000-02-17
March, 2001 FDA 483 DentSply Sirona - Form 483, 2001-03-15
August, 2001 FDA 483 Concept Laboratories - Form 483, 2001-08-23

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more